Fresenius SE Other Non-Current Liabilities 2016-2024 | FSNUY

Fresenius SE other non-current liabilities for the quarter ending September 30, 2024 were $1.317B, a 32.38% decline year-over-year.

  • Fresenius SE other non-current liabilities for 2023 were $2.01B, a 37.33% decline from 2022.
  • Fresenius SE other non-current liabilities for 2022 were $3.207B, a 40.75% increase from 2021.
  • Fresenius SE other non-current liabilities for 2021 were $2.279B, a 9% decline from 2020.

Fresenius SE Other Non-Current Liabilities 2016-2024 | FSNUY

  • Fresenius SE other non-current liabilities for 2023 were $2.01B, a 37.33% decline from 2022.
  • Fresenius SE other non-current liabilities for 2022 were $3.207B, a 40.75% increase from 2021.
  • Fresenius SE other non-current liabilities for 2021 were $2.279B, a 9% decline from 2020.
Related Stocks
Company NameMarket
Cap
Quest Diagnostics (DGX)$17.3B
DaVita (DVA)$14.2B
Encompass Health (EHC)$9.6B
Chemed (CHE)$8.4B
Elanco Animal Health (ELAN)$6.1B
Option Care Health (OPCH)$5.3B
RadNet (RDNT)$5B
LifeStance Health (LFST)$3.1B
Amedisys (AMED)$3B
Addus HomeCare (ADUS)$2.3B
Astrana Health (ASTH)$2.1B
U.S Physical Therapy (USPH)$1.3B
Pennant (PNTG)$945M
Aveanna Healthcare Holdings (AVAH)$945M
Atai Life Sciences (ATAI)$252M
Bioqual (BIOQ)$55M
Daxor (DXR)$38M
Ontrak (OTRK)$7M
MEDIROM Healthcare Technologies (MRM)$4M
IMAC Holdings (BACK)$2M
Psychemedics (PMD)$0M